These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36218309)

  • 1. Impact of exacerbations on lung function, resource utilization, and productivity: results from an observational, prospective study in adults with uncontrolled asthma.
    Wisnivesky J; Federmann E; Eckert L; West E; Amand C; Kamar D; Teper A; Khan AH
    J Asthma; 2023 Jun; 60(6):1072-1079. PubMed ID: 36218309
    [No Abstract]   [Full Text] [Related]  

  • 2. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan.
    Nagase H; Tamaoki J; Suzuki T; Nezu Y; Akiyama S; Cole AL; Yang S; Mu G; Katsumata M; Komatsubara M; Alfonso-Cristancho R
    Pulm Pharmacol Ther; 2022 Aug; 75():102130. PubMed ID: 35714883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of Irreversible Airflow Limitation in Asthma: Correlation with Severe Exacerbations.
    Matsunaga K; Hirano T; Oka A; Tanaka A; Kanai K; Kikuchi T; Hayata A; Akamatsu H; Akamatsu K; Koh Y; Nakanishi M; Minakata Y; Yamamoto N
    J Allergy Clin Immunol Pract; 2015; 3(5):759-64.e1. PubMed ID: 26054551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
    Golam SM; Janson C; Beasley R; FitzGerald JM; Harrison T; Chipps B; Hughes R; Müllerová H; Olaguibel JM; Rapsomaniki E; Reddel HK; Sadatsafavi M;
    Respir Med; 2022; 200():106863. PubMed ID: 35952579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of asthma exacerbation among patients with poorly controlled asthma despite inhaled corticosteroid treatment.
    Quezada W; Kwak ES; Reibman J; Rogers L; Mastronarde J; Teague WG; Wei C; Holbrook JT; DiMango E
    Ann Allergy Asthma Immunol; 2016 Feb; 116(2):112-7. PubMed ID: 26712474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study).
    Niven RM; Saralaya D; Chaudhuri R; Masoli M; Clifton I; Mansur AH; Hacking V; McLain-Smith S; Menzies-Gow A
    BMJ Open; 2016 Aug; 6(8):e011857. PubMed ID: 27507234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations and healthcare resource utilization among COPD patients in a Swedish registry-based nation-wide study.
    Johansson G; Mushnikov V; Bäckström T; Engström A; Khalid JM; Wall J; Hoti F
    BMC Pulm Med; 2018 Jan; 18(1):17. PubMed ID: 29370846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of omalizumab in severe allergic asthma: a retrospective UK real-world study.
    Barnes N; Menzies-Gow A; Mansur AH; Spencer D; Percival F; Radwan A; Niven R
    J Asthma; 2013 Jun; 50(5):529-36. PubMed ID: 23574000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD009611. PubMed ID: 23450606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 measures on exacerbation rates and healthcare visits in US asthma patients.
    Karcher H; Schoenberger M; Rayban T; Kelly C; Heaney A; Mackay A
    Allergy Asthma Proc; 2023 Nov; 44(6):422-428. PubMed ID: 37919845
    [No Abstract]   [Full Text] [Related]  

  • 16. Children with Asthma Have Fixed Airway Obstruction through Childhood Unaffected by Exacerbations.
    Hallas HW; Chawes BL; Arianto L; Rasmussen MA; Kunøe A; Stokholm J; Bønnelykke K; Bisgaard H
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1263-1271.e3. PubMed ID: 31707066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe exacerbations predict excess lung function decline in asthma.
    Bai TR; Vonk JM; Postma DS; Boezen HM
    Eur Respir J; 2007 Sep; 30(3):452-6. PubMed ID: 17537763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol.
    Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-Year follow-up.
    Sousa AW; Barros Cabral AL; Arruda Martins M; Carvalho CRF
    Pediatr Pulmonol; 2020 Mar; 55(3):591-598. PubMed ID: 31909900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.